Trastuzumab Completed Phase 3 Trials for Neoplasms, Breast Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00320385 | Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer | |
NCT01125566 | LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment | |
NCT00021255 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer |